Immunosuppression and Human Malignancy

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology
Cover of the book Immunosuppression and Human Malignancy by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan, Humana Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan ISBN: 9781461244967
Publisher: Humana Press Publication: December 6, 2012
Imprint: Humana Language: English
Author: David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
ISBN: 9781461244967
Publisher: Humana Press
Publication: December 6, 2012
Imprint: Humana
Language: English

The immune system can deal effectively with the majority of viruses and bacteria, less effectively with parasites, and very poorly with cancer. Why is this so? Why are McFarlane Burnet's and Lewis Thomas' predictions that the immune system is in­ volved in ridding the body of cancer cells, encapsulated in the catchy phrase "immunologic surveillance," so difficult to experi­ mentally establish? Cancer differs from infectious agents in being derived from the host. Hence, it has been postulated that cancer cells lack anti­ gens that the immune system can recognize. They are not "im­ munogenic. " However, this argument is seriously weakened by the existence of numerous human autoimmune diseases, in which the immune system effectively recognizes and attacks a va­ riety of self tissues. Thus, the potential clearly exists for recogni­ tion of the surfaces of tumor cells. Professor Naor and his colleagues have written a book that explores another possible reason: cancer cells are recognized by the immune system-but is it possible that the consequence of recognition is inhibition of the immune system-by suppressor T cells or macrophages? The evolution of the malignant state may only occur in individuals who develop this suppression. This book reviews the evidence that suppressor cells, poorly characterized and difficult to study, may be of fundamental im­ portance in cancer. In fact, our incapacity to understand the na­ ture of suppressor cells and their mode of action is one of the ma­ jor problems in immunology research today.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The immune system can deal effectively with the majority of viruses and bacteria, less effectively with parasites, and very poorly with cancer. Why is this so? Why are McFarlane Burnet's and Lewis Thomas' predictions that the immune system is in­ volved in ridding the body of cancer cells, encapsulated in the catchy phrase "immunologic surveillance," so difficult to experi­ mentally establish? Cancer differs from infectious agents in being derived from the host. Hence, it has been postulated that cancer cells lack anti­ gens that the immune system can recognize. They are not "im­ munogenic. " However, this argument is seriously weakened by the existence of numerous human autoimmune diseases, in which the immune system effectively recognizes and attacks a va­ riety of self tissues. Thus, the potential clearly exists for recogni­ tion of the surfaces of tumor cells. Professor Naor and his colleagues have written a book that explores another possible reason: cancer cells are recognized by the immune system-but is it possible that the consequence of recognition is inhibition of the immune system-by suppressor T cells or macrophages? The evolution of the malignant state may only occur in individuals who develop this suppression. This book reviews the evidence that suppressor cells, poorly characterized and difficult to study, may be of fundamental im­ portance in cancer. In fact, our incapacity to understand the na­ ture of suppressor cells and their mode of action is one of the ma­ jor problems in immunology research today.

More books from Humana Press

Cover of the book Surgical Pathology of Endocrine and Neuroendocrine Tumors by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book Peroxisome Proliferator-Activated Receptors by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book The Rise of Experimental Biology by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book Sleep Disorders in Women by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book Pain in Children by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book Iron Physiology and Pathophysiology in Humans by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book Cardiovascular Hemodynamics by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book 5-HT2C Receptors in the Pathophysiology of CNS Disease by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book Robotic and Laparoscopic Reconstructive Surgery in Children and Adults by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book Heart Disease and Erectile Dysfunction by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book Diabetes and the Brain by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book Cancer Stem Cells in Solid Tumors by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book Urethral Reconstructive Surgery by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book Long-Term Care Medicine by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
Cover of the book Cytology and Surgical Pathology of Gynecologic Neoplasms by David Naor, Benjamin Y. Klein, Nora Tarcic, Jonathan S. Duke-Cohan
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy